ResMed (RMD) revenue

Revenue · fiscal 2026
$5.65B

ResMed (RMD) reported revenue of $5.65B in fiscal 2026 (the year ended June 30, 2026). That is 9.9% higher than the $5.15B of fiscal 2025. Figures as of 18 Nov 2026, 08:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2026
$5.65B
Change on fiscal 2025
+9.9%
Growth, 5 years
+12.1% a year
Growth, 10 years
+11.9% a year
Highest on record
$5.65Bfiscal 2026
Lowest on record
$920.74Mfiscal 2009
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ResMed revenue, in more detail

Over the five fiscal years to 2026 revenue grew at a compound 12.1% a year; over ten years the rate was 11.9% a year. Across the 18 fiscal years on record (2009–2026), the highest was $5.65B in fiscal 2026 and the lowest $920.74M in fiscal 2009.

History · 18 fiscal years

Revenue by fiscal year

ResMed revenue, year by year

ResMed (RMD) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2026$5.65B 9.9% up
2025$5.15B 9.8% up
2024$4.69B 10.9% up
2023$4.22B 18.0% up
2022$3.58B 11.9% up
2021$3.20B 8.1% up
2020$2.96B 13.4% up
2019$2.61B 11.4% up
2018$2.34B 13.2% up
2017$2.07B 12.4% up
2016$1.84B 9.5% up
2015$1.68B 8.0% up
2014$1.55B 2.7% up
2013$1.51B 10.7% up
2012$1.37B 10.1% up
2011$1.24B 13.8% up
2010$1.09B 18.6% up
2009$920.74M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of ResMed and comparable companies
CompanyRevenueFiscal year
Mettler-Toledo International MTD$4.03B2025
Centene CNC$194.78B2025
Genmab GMAB$3.72B2025
Illumina ILMN$4.34B2025
ResMed RMD$5.65B2026
Zoetis ZTS$9.47B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RMD

ResMed, figure by figure

ResMed (RMD) overview: price, valuation and scorecardAll health care companies by market value

ResMed revenue: questions and answers

What is ResMed's revenue?

ResMed (RMD) reported revenue of $5.65B in fiscal 2026 (the year ended June 30, 2026). That is 9.9% higher than the $5.15B of fiscal 2025.

What is the growth rate of ResMed's revenue?

Over the five fiscal years to 2026 revenue grew at a compound 12.1% a year; over ten years the rate was 11.9% a year.

What are the highest and lowest revenue figures on record for ResMed?

Across the 18 fiscal years on record (2009–2026), the highest was $5.65B in fiscal 2026 and the lowest $920.74M in fiscal 2009.

How is ResMed's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ResMed (RMD) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RMD/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.